Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and
the co-Leader of the Tumor Immunology and Immunotherapy research program.
Not exact matches
«We have experiments in mice that show that the combined use
of PD - 1 antibody and poly - IC is synergistic for the recognition
of tumors and an antitumor response mediated by T - cells,» says Dr. Esteban Celis,
co-leader of the Cancer
Immunology, Inflammation and Tolerance program at the Georgia Cancer Center at Augusta University.
Co-Leader, Host -
Tumor Interactions Research Program Louise B. McGavock Professor
of Pathology, Microbiology and
Immunology Assistant Vice Chancellor for Integrative Diagnostics